Phase 2 I’ve written previously about how expensive clinical trials are, and how not many companies are actually cashed enough to run the trials they plan on. Companies need…
top shroom stocks
MAPS, FDA & Health Canada In a highly regulated sector like psychedelics, governing bodies like the FDA and Health Canada have the power to shape and influence how an…
SEO I’ve stayed pretty positive with regard to the psychedelics space so far, and while the company I am going to be talking about here isn’t a psychedelics company…
Steady as she goes It’s been a rough couple of quarters for the psychedelics sector at large. Some companies have been able to avoid the correction, but for the…
Rollbacks Yesterday Core One Labs (COOL.C) announced an 8:1 share rollback to prepare itself for a Nasdaq listing. Today the company has 114,600,611 common shares outstanding, after the rollback,…
Brain trauma/CTE Lobe Sciences (LOBE.C) is working to develop effective psychedelic-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder with a focus on contact…